MannKind to Present at the Fourth Annual JMP Securities Healthcare Focus Conference

Tue, 29 Sep 2009 21:00:00 0500

VALENCIA, Calif.-(Business Wire)-September 29, 2009 - MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Fourth Annual JMP Securities Healthcare Focus Conference

SATAI Announces $1.045 Million Emerging Technology Fund Investment in Azaya Therapeutics, Inc.

Tue, 29 Sep 2009 20:04:00 0500

SAN ANTONIO-(Business Wire)-September 29, 2009 - SATAI (www.satai.us) and the South Texas Regional Center of...

Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit

Tue, 29 Sep 2009 18:10:00 0500

PHILADELPHIA-(Business Wire)-September 29, 2009 - Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

Clinical Data, Inc. to Present at the JMP Securities Healthcare Focus Conference

Tue, 29 Sep 2009 17:25:00 0500

NEWTON, Mass.-(Business Wire)-September 29, 2009 - Clinical Data, Inc. (NASDAQ: CLDA), today announced...

Rosetta Genomics to Present at the 2009 Maxim Group Growth Conference

Tue, 29 Sep 2009 16:39:00 0500

PHILADELPHIA & REHOVOT, Israel-(Business Wire)-September 29, 2009 - Rosetta Genomics, Ltd. (NASDAQ:ROSG) a leading developer of microRNA-based molecular diagnostics, announced that management will present a corporate update at the 2009 Maxim Group Growth Conference today, Tuesday...

Todd Cancer Institute at Long Beach Memorial Medical Center and Miller Children’s Hospital Granted Approval for Proton Therapy Project

Tue, 29 Sep 2009 16:00:00 0500

LONG BEACH, Calif.-(Business Wire)-September 29, 2009 - The

Computable Genomix Announces Contest For Genomics Researchers

Tue, 29 Sep 2009 12:00:00 0500

MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool.

Publish or Perish will...

SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing

Tue, 29 Sep 2009 12:00:00 0500

MADISON, Wis.-(Business Wire)-September 29, 2009 - National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), and Roche Applied Science, a division of Roche Diagnostics Corporation (SWX:RO) (SWX:ROG) (Pink...

Aurora Breast MRI of Sarasota and Clear Channel Radio, Partner for “Change for Change” Fundraising Event

Tue, 29 Sep 2009 11:29:00 0500

SARASOTA, Fla.-(Business Wire)-September 29, 2009 - Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled “Change for Change,” will consist of a series...

State Farm Receives CEO Cancer Gold StandardTM Accreditation

Tue, 29 Sep 2009 11:00:00 0500

CARY, N.C.-(Business Wire)-September 29, 2009 - State Farm has received CEO Cancer Gold Standard^™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings...

Seattle Cancer Care Alliance, ProCure to Develop Proton Therapy Center

Tue, 29 Sep 2009 04:01:00 0500

SEATTLE & BLOOMINGTON, Ind.-(Business Wire)-September 29, 2009 - The development of a proton therapy center in the Pacific Northwest has taken a significant step forward with the signing of a letter of intent between the Seattle Cancer Care Alliance (SCCA) and ProCure Treatment Centers Inc...

Maxygen Announces Management Changes

Mon, 28 Sep 2009 20:05:00 0500

REDWOOD CITY, Calif.-(Business Wire)-September 28, 2009 - Maxygen, Inc. (Nasdaq:MAXY) announced today that James Sulat, who currently serves as a director of the company, has been appointed to serve as Maxygen’s Chief Executive Officer, effective October 1, 2009. Mr. Sulat will replace...

Burzynski Research Institute Signs Research Agreement with the University of Alabama at Birmingham (UAB), Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility

Mon, 28 Sep 2009 19:14:00 0500

HOUSTON-(Business Wire)-September 28, 2009 - The Burzynski Research Institute, Inc. (BRI) today announced that it has signed a Research Agreement with the UAB Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility (BBSF) that will provide biostatistical and data...

Research and Markets: Launching Next Generation Oncology Products as Market to Grow to US$75-80 billion by 2012: Evolving Strategies in a Payor's Market

Mon, 28 Sep 2009 16:30:00 0500

DUBLIN-(Business Wire)-September 28, 2009 - Research and Markets (

Saint John’s Health Center Appoints Internationally Recognized Neurosurgeon

Mon, 28 Sep 2009 12:00:00 0500

SANTA MONICA, Calif.-(Business Wire)-September 28, 2009 - Saint John’s Health Center today announced the appointment of world-renowned neurosurgeon Amin Kassam, MD, as Director of the new Saint John’s Neuroscience Institute and faculty member of the John Wayne Cancer Institute at Saint...

Helicos Announces System Sale to Correlagen Diagnostics

Mon, 28 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis.

“We are very...

Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies

Mon, 28 Sep 2009 11:00:00 0500

CARLSBAD, Calif. & HEIDELBERG, Germany-(Business Wire)-September 28, 2009 - febit holding GmbH

Inovio Biomedical to Present at Vaccine 3rd Global Congress

Mon, 28 Sep 2009 08:00:00 0500

SAN DIEGO-(Business Wire)-September 28, 2009 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it will make multiple presentations at the Vaccine 3^rd Global Congress being held in Singapore October 4^th

Photos of Sarah Chalke Supporting Breast Cancer Awareness Available on Business Wire's Web Site and AP PhotoExpress

Sun, 27 Sep 2009 22:50:00 0500

-(Business Wire)-September 27, 2009 - Actress Sarah Chalke attends Susan G. Komen Orange County Race for the Cure®.

Photo one:

(race 4) Actress Sarah Chalke (right), ambassador for the Susan G. Komen Passionately Pink for the Cure® program, and...

UPDATE on Advisory/New Satellite Coordinates for New World Record for Female Formation Skydive to Benefit Breast Cancer Awareness

Sun, 27 Sep 2009 20:19:00 0500

-(Business Wire)-September 27, 2009 - Jump for the Cause wishes to issue the following update to its release NewsItemID 20090927005029 (CA-JUMP-FOR-THE-CAUSE) "Advisory/Satellite Coordinates for New World Record for Female Formation Skydive to Benefit Breast Cancer Awareness" issued earlier...

Advisory/Satellite Coordinates for New World Record for Female Formation Skydive to Benefit Breast Cancer Awareness

Sun, 27 Sep 2009 12:00:00 0500

-(Business Wire)-September 27, 2009 - Jump for the Cause:

Who:

A-Life Medical, Inc. to Exhibit at the American College of Emergency Physician (ACEP) Scientific Assembly

Thu, 24 Sep 2009 20:26:00 0500

WHO:

Advaxis, Inc. (OTCBB: ADXS), the live...

Arizona Residents Greg and Lauren Glassman Recognized for Their Support in Fighting Cancer

Thu, 24 Sep 2009 19:00:00 0500

SANTA MONICA, Calif.-(Business Wire)-September 24, 2009 - Greg and Lauren Glassman, founders of CrossFit, Inc., are providing crucial funding for the battle against prostate cancer. In acknowledgement of CrossFit’s annual Fight Gone Bad event that has raised more than $1 million since...

Imprime PGG® Named a Top 10 Oncology Drug Candidate for Partnering

Thu, 24 Sep 2009 16:44:00 0500

EAGAN, Minn.-(Business Wire)-September 24, 2009 - Biothera, a privately held biotechnology company, announced today that its lead drug candidate, Imprime PGG^®, has been named one of the Top 10 Most Interesting Oncology Projects Available for Partnering by Windhover...

Susan G. Komen Races for the Cure across Europe

Thu, 24 Sep 2009 15:28:00 0500

WASHINGTON, D.C.-(Business Wire)-September 24, 2009 - A sea of pink t-shirts will stretch from Athens to Bologna to Frankfurt to Zurich to Antwerp today in an effort to raise public awareness about breast cancer. In five cities across Europe, breast cancer survivors, their families, friends...

TRADE NEWS: Agilent Technologies, Shanghai Institute of Biological Sciences and Chinese Academy of Sciences Open Center for Systems Biology

Thu, 24 Sep 2009 15:00:00 0500

SANTA CLARA, Calif. & SHANGHAI-(Business Wire)-September 24, 2009 - Agilent Technologies Inc. (NYSE:A) today announced the opening of the Shanghai Institute of Biological Sciences (SIBS)-Agilent Center for Systems Biology in Shanghai, China. The center will feature multiple technology...

CEO Roundtable on Cancer Recognizes Aetna for Commitment to Improving the Health and Well-Being of Employees and Their Families

Thu, 24 Sep 2009 13:56:00 0500

HARTFORD, Conn.-(Business Wire)-September 24, 2009 - The CEO Roundtable on Cancer today recognized Aetna (NYSE:AET) with a CEO Cancer Gold Standard^TM accreditation for the company’s commitment to improving the health of employees and their families. To receive the accreditation...

Research and Markets: Nuclear Oncology Covers Imaging, Dosimetric, And Therapeutic Applications of Radiopharmaceuticals and Metabolic Imaging Agents

Thu, 24 Sep 2009 13:30:00 0500

DUBLIN-(Business Wire)-September 24, 2009 - Research and Markets(Genzyme Corporation (Nasdaq: GENZ) announced today...

IsoRay Inc. Announces Fiscal Year 2009 Results

Thu, 24 Sep 2009 12:30:00 0500

RICHLAND, Wash.-(Business Wire)-September 24, 2009 - IsoRay Inc. (AMEX:ISR), a medical isotope company focused on the treatment of lung cancer, head and neck tumors, prostate cancer and other malignant disease through use of its proprietary radioisotope technology, announces today its financial...

Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation

Thu, 24 Sep 2009 12:28:00 0500

BERLIN-(Business Wire)-September 24, 2009 - Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC...

BSD Medical Corporation Files $50 Million Shelf Registration

Thu, 24 Sep 2009 12:00:00 0500

SALT LAKE CITY-(Business Wire)-September 24, 2009 - BSD Medical Corporation (NASDAQ:BSDM) (

Philips and Celsion Advance Development of ThermoDox® and MR-Guided HIFU

Wed, 23 Sep 2009 12:00:00 0500

ANDOVER, Mass. & COLUMBIA, Md.-(Business Wire)-September 23, 2009 - Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High...

The International Myeloma Foundation to Hold Washington Meeting on Drug Regulation and Reimbursement to Make Health Reform Meaningful and Cost-Effective for Patients with Rare Cancers

Wed, 23 Sep 2009 11:32:00 0500

NORTH HOLLYWOOD, Calif.-(Business Wire)-September 23, 2009 - The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians—today said health reform must move beyond the current government...

GE Healthcare Launches Global Initiative to Celebrate 10th Anniversary of Digital Mammography

Wed, 23 Sep 2009 10:14:00 0500

BUC, France-(Business Wire)-September 23, 2009 - In addition to being Breast Cancer Awareness Month, this October is the tenth anniversary of digital mammography, a technology introduced by GE Healthcare (NYSE:GE) in 1999. Similar to digital photography, digital mammography replaces the film used...

Idera Pharmaceuticals Presents Interim Data from Phase 1b Clinical Trial of IMO-2055 in Combination with Tarceva® and Avastin® in Non-Small Cell Lung Cancer

Wed, 23 Sep 2009 10:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 23, 2009 - Idera Pharmaceuticals (Nasdaq: IDRA) today presented interim data from a phase 1b, single arm clinical trial evaluating IMO-2055, an agonist of Toll-like Receptor (TLR) 9, in combination with Tarceva^® and Avastin^® in...

Plexxikon Announces Encouraging Data from Phase 1 Extension Study of PLX4032 Showing Objective Responses in Metastatic Melanoma Patients

Wed, 23 Sep 2009 09:15:00 0500

BERLIN, Germany & BERKELEY, Calif.-(Business Wire)-September 23, 2009 - Plexxikon Inc. today announced encouraging clinical data from a Phase 1 extension study of PLX4032 (RG7204) in metastatic melanoma patients, which expand the results announced from the initial phase of the study...

Miley Cyrus, Demi Lovato and Jesse McCartney to Perform at Second Annual Concert for Hope Presented by Staples, Inc., October 25 at Nokia Theatre L.A. LIVE

Tue, 22 Sep 2009 23:40:00 0500

LOS ANGELES-(Business Wire)-September 22, 2009 - Disney Music Group artists Miley Cyrus, Demi Lovato and Jesse McCartney will hit all the right notes in the fight against cancer when they take the stage at the second annual Concert for Hope presented by Staples, Inc. on Sunday, October 25...

Spectrum Pharmaceuticals Receives $50 Million from Institutional Investors at $7.55 Per Share

Tue, 22 Sep 2009 23:31:00 0500

IRVINE, Calif.-(Business Wire)-September 22, 2009 - Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus primarily in oncology, today announced that it has received $50 million from existing institutional investors in a previously announced...

Susan G. Komen for the Cure® Founder Nancy G. Brinker Warns of Coming Global Cancer Crisis; Calls on World Leaders at United Nations to “Include Cancer” on Health Agendas

Tue, 22 Sep 2009 23:15:00 0500

NEW YORK-(Business Wire)-September 22, 2009 - The leader of the global breast cancer movement today warned of a coming wave of cancer deaths and told global health ministers to be “fearless and united” in addressing the growing cancer crisis, particularly in developing countries...

BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger

Tue, 22 Sep 2009 22:30:00 0500

LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 22, 2009 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that they have determined the final exchange ratio as 0.1828 in connection with the previously announced...

BioAlliance Pharma Announces That the Civil Action Filed by Eurofins in the United States is Rejected

Tue, 22 Sep 2009 17:00:00 0500

Regulatory News:

BioAlliance Pharma SA (Paris:BIO) announces today that the American District Judge has granted the motion to dismiss of BioAlliance Pharma and one of its executive in response to the civil action filed by Eurofins. Eurofins filed...

Bio-Path Holdings, Inc. Announces Plans to Develop Liposome Tumor Targeting Technology Licensed from The University of Texas M. D. Anderson Cancer Center

Tue, 22 Sep 2009 16:54:00 0500

HOUSTON-(Business Wire)-September 22, 2009 - Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today the Company has executed an exclusive license with The University of Texas M. D. Anderson Cancer Center...

Secretary Sebelius Joins NCAA Basketball Coaches to Rally for Health Insurance Reform

Tue, 22 Sep 2009 15:56:00 0500

WASHINGTON-(Business Wire)-September 22, 2009 - HHS Secretary Kathleen Sebelius today joined five NCAA Division I basketball coaches, Senators Robert Casey, Al Franken and Amy Klobuchar, and cancer survivors and advocates from the American Cancer Society Cancer Action Network to rally in...

MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study

Tue, 22 Sep 2009 15:53:00 0500

BERLIN-(Business Wire)-September 22, 2009 - MagForce Nanotechnologies AG (FWB:MF6) has successfully completed patient recruitment for its study on recurrent glioblastoma, which is of critical importance for demonstrating the efficacy of its proprietary Nano-Cancer^® therapy. The...

Research and Markets: Lynn Sage Breast Cancer Symposium - a Forum of Discussions and Presentations in Laboratory and Clinical Research Concerning the Care of Patients with Breast Cancer

Tue, 22 Sep 2009 15:00:00 0500

DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets (Baron & Budd, P.C. has sponsored the publication of a...

Cancer Patients Not Given Adequate Information on Fertility Preservation

Tue, 22 Sep 2009 13:00:00 0500

CHICAGO-(Business Wire)-September 22, 2009 - Life-saving cancer treatments such as chemotherapy and radiation can destroy the reproductive potential of both men and women; an added struggle for the 130,000 people in the US diagnosed with cancer each year. The good news is that advances in...

Barclays/Nets Community Alliance Partners with Camp Sunshine to Support Hematology and Oncology Program

Tue, 22 Sep 2009 13:00:00 0500

CASCO, Maine-(Business Wire)-September 22, 2009 - Today, Camp Sunshine announced it has received support from the Barclays/Nets Community Alliance, which includes a partnership among Barclays, the Nets and Forest City Ratner Companies. This support is enabling a special session at Casco, Maine...

Curis to Present at Maxim Group Growth Conference 2009

Tue, 22 Sep 2009 12:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Maxim Group Growth Conference...

BSD Medical Reports News Briefing at Europe’s Largest Cancer Congress: Hyperthermia and Chemotherapy Treatment Prolongs Survival of Sarcoma Cancer Patients

Tue, 22 Sep 2009 12:00:00 0500

SALT LAKE CITY-(Business Wire)-September 22, 2009 - BSD Medical Corporation (NASDAQ:BSDM) reports that significant and “medical practice changing” clinical study results were the subject of a news briefing at Europe’s largest cancer congress, ECCO15 – ESMO34, which is being held September...

Helicos Presents at Cold Spring Harbor Laboratories Personal Genomes and CHI Next Generation Sequencing Meetings

Tue, 22 Sep 2009 11:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) provided updates on recent scientific findings and progress on Helicos’s technology initiatives.

Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the...

Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer’s AROMASIN® (Exemestane Tablets)

Tue, 22 Sep 2009 11:00:00 0500

BERLIN-(Business Wire)-September 22, 2009 - Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the...

Research and Markets: Board Review in Medical Oncology

Tue, 22 Sep 2009 08:59:00 0500

DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets (HealthPort, a top-25 company in the...

Vertex Pharmaceuticals Employees Participate in First Companywide Day of Service

Mon, 21 Sep 2009 19:42:00 0500

CAMBRIDGE, Mass., SAN DIEGO, OXFORDSHIRE, U.K. & CORALVILLE, Iowa-(Business Wire)-September 21, 2009 - Bio Nebraska Life Sciences...

AngioDynamics to Hold Fiscal 2010 First Quarter Financial Results Conference Call on October 6, 2009

Mon, 21 Sep 2009 19:05:00 0500

QUEENSBURY, N.Y.-(Business Wire)-September 21, 2009 - AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it...

Women's Focus III, Breast Cancer Awareness Month Feature Release

Mon, 21 Sep 2009 19:03:00 0500

SAN FRANCISCO-(Business Wire)-September 21, 2009 - The following release focuses on the topic Women's Focus III, Breast Cancer Awareness Month

ALL TIME-OFFS ARE IN EASTERN TIME, UNLESS NOTED STORIES MOVED AT 4:35 AM ET ON SEPTEMBER 21, 2009.

BOISE...

Advaxis Granted New Compositions and Methods Patent

Mon, 21 Sep 2009 17:33:00 0500

NORTH BRUNSWICK, N.J.-(Business Wire)-September 21, 2009 - The United States Patent and Trademark Office (USPTO) has granted and issued www.jumpforthecause.com

Antigenics Announces Expansion of Its QS-21 License Agreement

Mon, 21 Sep 2009 15:15:00 0500

LEXINGTON, Mass.-(Business Wire)-September 21, 2009 - Antigenics Inc. (NASDAQ: AGEN) today announced that the company has signed an amended and restated license agreement for the use of the QS-21 adjuvant in a vaccine under development by JANSSEN Alzheimer Immunotherapy, a company which has...

Sloning Closes Growth Financing Round Led by LBBW Venture

Mon, 21 Sep 2009 13:41:00 0500

PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...

Reportlinker Adds Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market

Mon, 21 Sep 2009 13:15:00 0500

NEW YORK-(Business Wire)-September 21, 2009 - Reportlinker.com announces that a new market research report is available in its catalogue.

High Content Analysis East conference...

ARIAD Announces Clinical Data from Phase 1 Study of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Bevacizumab

Mon, 21 Sep 2009 11:35:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 21, 2009 - ARIAD Pharmaceuticals, Inc. (Nasdaq...

Provectus Completes Treatment of All Patients in Phase 2 Trial of PV-10 for Metastatic Melanoma

Mon, 21 Sep 2009 11:30:00 0500

KNOXVILLE, Tenn.-(Business Wire)-September 21, 2009 - Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has completed the treatment portion, including all protocol-allowed retreatments of all patients, of its Phase 2 clinical...

Data Safety Monitoring Board Recommends Continuation of Celsion’s Phase III ThermoDox® Study for Primary Liver Cancer

Mon, 21 Sep 2009 11:30:00 0500

COLUMBIA, Md.-(Business Wire)-September 21, 2009 - Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board (“DSMB”) has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer...

Semafore Retains Management Consulting Firm; Names Principal to Key Management Position

Mon, 21 Sep 2009 11:00:00 0500

INDIANAPOLIS-(Business Wire)-September 21, 2009 - Semafore Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics targeting the phosphoinositide-3-kinase (PI3K) pathway for the treatment of cancer and other...

David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics

Mon, 21 Sep 2009 10:00:00 0500

DUBLIN, Calif.-(Business Wire)-September 21, 2009 - SuperGen Inc. (Nasdaq:SUPG) announced that, effective October 16, 2009, David Bearss, Ph.D., will resign as SuperGen’s Chief Scientific Officer, and be engaged as a long-term biology consultant to the Company. In addition, Dr. Bearss will...

Wear Ease Designs the Latest Fashions with Mastectomy Patients in Mind

Mon, 21 Sep 2009 08:35:00 0500

BOISE, Idaho-(Business Wire)-September 21, 2009 - One in eight U.S. women will be diagnosed with breast cancer during their lifetime, and currently slightly more than half, 56 percent, undergo mastectomy. Few fashion options exist for those who don’t seek reconstructive surgery or postpone it...

Rodman & Renshaw Exclusive Placement Agent for Spectrum Pharmaceuticals

Fri, 18 Sep 2009 23:20:00 0500

NEW YORK-(Business Wire)-September 18, 2009 - Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), today announced that its client Spectrum Pharmaceuticals, Inc. (NasdaqGM:

FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE® (bortezomib) for Injection

Fri, 18 Sep 2009 14:18:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 18, 2009 - Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the Company’s supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall...

BSD Medical Corporation Reports FDA Review of BSD-2000 Hyperthermia System Continues

Fri, 18 Sep 2009 14:15:00 0500

SALT LAKE CITY-(Business Wire)-September 18, 2009 - BSD Medical Corporation (NASDAQ: BSDM) (Vertex Pharmaceuticals Incorporated

InSight Health Services Holdings Corp. Reports Results for the Fourth Quarter and Fiscal Year Ended June 30, 2009

Thu, 17 Sep 2009 20:54:00 0500

LAKE FOREST, Calif.-(Business Wire)-September 17, 2009 - InSight Health Services Holdings Corp. (“InSight”) (OTCBB: ISGT) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2009.

Kip Hallman, InSight’s President and CEO, stated, “I...

Pancreatic and Colorectal Cancer Novel Antibody Developed from a Vaccine to Begin Phase I Trial

Thu, 17 Sep 2009 20:28:00 0500

GREAT NECK, N.Y.-(Business Wire)-September 17, 2009 - Neogenix Oncology, Inc. (Neogenix) announced today that NPC-1C, the company’s first IND (Investigational New Drug Application) was granted permission by the Food and Drug Administration (FDA) for the company to begin a Phase I...

3rd Annual Denver Cook for the Cure© to Be Held October 22, 2009

Thu, 17 Sep 2009 20:22:00 0500

DENVER-(Business Wire)-September 17, 2009 - Cook for the Cure^© on Thursday, October 22nd is a delicious way for breast cancer survivors and their supporters to help fight the battle against breast cancer while enjoying great food and fun cooking demonstrations. This one-of-a-kind...

Seattle Genetics to Present at UBS Global Life Sciences Conference

Thu, 17 Sep 2009 20:00:00 0500

BOTHELL, Wash.-(Business Wire)-September 17, 2009 - Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present at the 2009 UBS Global Life Sciences Conference on Tuesday, September 22, 2009, at 2:00 p.m. Eastern...

Hythiam Raises Approximately $7 Million in Registered Direct Offering

Thu, 17 Sep 2009 17:33:00 0500

LOS ANGELES-(Business Wire)-September 17, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that it has entered into definitive agreements to sell 9,333,334 shares of its common stock at a price per share of $.75 to institutional investors pursuant to a registered direct offering...

Medifocus, Inc. Files Response to its Investigational Device Exemption (IDE) With the Food and Drug Administration (FDA) in the United States for its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer

Thu, 17 Sep 2009 16:42:00 0500

VANCOUVER-(Business Wire)-September 17, 2009 - Medifocus, Inc. (TSXV:MFS) is pleased to announce that it has filed a comprehensive response to its IDE application with the FDA in the United States to obtain clearance to initiate a pivotal phase III clinical trial using the Company’s...

Research and Markets: PET/CT and SPECT/CT to Plan and Monitor the Treatment of Cancer

Thu, 17 Sep 2009 15:00:00 0500

DUBLIN-(Business Wire)-September 17, 2009 - Research and Markets (Calypso Medical Technologies, Inc., a...

Snapfish by HP Invites Consumers to “Share to Care” During Breast Cancer Awareness Month

Thu, 17 Sep 2009 13:00:00 0500

PALO ALTO, Calif.-(Business Wire)-September 17, 2009 - Snapfish by HP (NYSE:HPQ), the No. 1 online photo...

ImmunoCellular Therapeutics’ Immunology Platform Featured in Report on the Future of Cancer Research

Thu, 17 Sep 2009 12:45:00 0500

LOS ANGELES-(Business Wire)-September 17, 2009 - ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by...

EKR Therapeutics to Present at the 2009 UBS Global Life Sciences Conference

Thu, 17 Sep 2009 12:12:00 0500

BEDMINSTER, N.J.-(Business Wire)-September 17, 2009 - EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing critical-care products for the hospital setting, today announced that Howard Weisman, CEO & President, will present at the UBS Global Life Sciences...

Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to Close on a License Agreement

Thu, 17 Sep 2009 12:00:00 0500

ROCKVILLE, Md.-(Business Wire)-September 17, 2009 - Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced that it has reached an agreement to close on...

Power3 Medical Products, Inc. Headlines Session at International Molecular Diagnostic Meeting in China

Thu, 17 Sep 2009 11:45:00 0500

HOUSTON-(Business Wire)-September 17, 2009 - Power3 Medical Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer biomarkers and diagnostic tests, announces further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver...

Meridian Health Receives CEO Cancer Gold StandardTM Accreditation

Thu, 17 Sep 2009 11:00:00 0500

CARY, N.C.-(Business Wire)-September 17, 2009 - Meridian Health has received CEO Cancer Gold Standard^™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings...

RiskMetrics Group – ISS Governance Services Recommends Stockholders Vote “FOR” BioSante and Cell Genesys Merger

Thu, 17 Sep 2009 11:00:00 0500

LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 17, 2009 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today jointly announced that RiskMetrics Group – ISS Governance Services, a leading proxy advisory firm, has recommended...

Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance

Thu, 17 Sep 2009 05:03:00 0500

SOUTH SAN FRANCISCO, Calif. & CAMBRIDGE, Mass.-(Business Wire)-September 17, 2009 - Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and Biogen Idec (Nasdaq:BIIB), today announced that a Phase III study (PRIMA) showed that patients with follicular...

ImmunoGen Announces Amgen has Licensed Rights to Use the Company’s TAP Technology for a Solid Tumor Target

Wed, 16 Sep 2009 20:01:00 0500

WALTHAM, Mass.-(Business Wire)-September 16, 2009 - ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that Amgen Inc. has licensed the exclusive right to use the Company’s maytansinoid Targeted Antibody Payload (TAP) technology...

ADAO Congratulates the Acting U.S. Surgeon General, Steven K. Galson, and Thanks the U.S. Senate for Efforts to Encourage Warning About Asbestos Dangers

Wed, 16 Sep 2009 18:23:00 0500

REDONDO BEACH, Calif.-(Business Wire)-September 16, 2009 - The Asbestos Disease Awareness Organization (ADAO) today announced its support for the Surgeon General’s statement acknowledging the dangers of asbestos and thanks the U.S. Senate for continued efforts to encourage a warning. The...

Provectus Pharmaceuticals Will Present at the Maxim Group Growth Conference on September 29, 2009

Wed, 16 Sep 2009 16:35:00 0500

KNOXVILLE, Tenn.-(Business Wire)-September 16, 2009 - Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, will present at the Maxim Group Growth Conference on September 29, 2009 at 9:00 a.m. Eastern Time. The conference will be...

Research and Markets: Skin Lymphoma - Can be Easily Misdiagnosed as Psoriasis or Dermatitis: The Illustrated Guide, 3rd Edition

Wed, 16 Sep 2009 15:00:00 0500

DUBLIN-(Business Wire)-September 16, 2009 - Research and Markets (Cyntellect, Inc., a privately-held life sciences company...

AVEO Pharmaceuticals Appoints William J. Slichenmyer, M.D., Sc.M., as Chief Medical Officer and Robert C. Young, M.D., to Board of Directors

Wed, 16 Sep 2009 12:30:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 16, 2009 - AVEO Pharmaceuticals, Inc., a biopharmaceutical company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced the appointment of William J. Slichenmyer...

Celsion’s ThermoDox® Study for RCW Breast Cancer Aired on ABC and CBS Affiliate Stations

Wed, 16 Sep 2009 11:30:00 0500

COLUMBIA, Md.-(Business Wire)-September 16, 2009 - Celsion Corporation (NASDAQ:CLSN) announced today the Company’s DIGNITY clinical trial evaluating the use of ThermoDox® in combination with hyperthermia for the treatment of Recurrent Chest Wall (RCW) Breast Cancer was aired during...

Spectrum Pharmaceuticals to Present at the UBS Global Life Sciences Conference

Wed, 16 Sep 2009 11:00:00 0500

IRVINE, Calif.-(Business Wire)-September 16, 2009 - Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a focus in oncology, announced today that an overview of the Company’s business strategy will be presented at the UBS Global Life Sciences...

Aptuit, Inc. Receives CEO Cancer Gold StandardTM Accreditation

Wed, 16 Sep 2009 11:00:00 0500

CARY, N.C.-(Business Wire)-September 16, 2009 - Aptuit, Inc. has received CEO Cancer Gold Standard^™ accreditation, recognizing the organization’s commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high...

Progenics Announces Promotion of Mark R. Baker to President and Appoints Him to Board of Directors

Wed, 16 Sep 2009 11:00:00 0500

TARRYTOWN, N.Y.-(Business Wire)-September 16, 2009 - Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the promotion of Mark R. Baker to the newly created position of President. Mr. Baker was also appointed to the Board of Directors. He will continue to report to Paul J. Maddon...

SuperGen to Present at Upcoming Investment Conferences

Wed, 16 Sep 2009 10:00:00 0500

DUBLIN, Calif.-(Business Wire)-September 16, 2009 - SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at two upcoming...

Report from Elekta’s Annual Meeting 2009

Tue, 15 Sep 2009 22:30:00 0500

STOCKHOLM, Sweden-(Business Wire)-September 15, 2009 - Regulatory News:

At the Annual General Meeting of Elekta AB (publ), 60 shareholders entitled to vote participated, representing 52 percent of the votes in the company.
• Dividend to shareholders of SEK 2.00 (1.75) per...

PPD Opens Global Central Lab in Singapore

Tue, 15 Sep 2009 20:09:00 0500

WILMINGTON, N.C.-(Business Wire)-September 15, 2009 - PPD, Inc. (Nasdaq: PPDI) today announced it has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customized laboratory services in Southeast Asia, a...

Medifacts Presents Free Symposium on “Meeting the Evolving Cardiac Safety Requirements from Diabetes to Oncology” at the North Carolina Biotech Center

Tue, 15 Sep 2009 15:31:00 0500

-(Business Wire)-September 15, 2009 - Medifacts International:

Duraflame Goes Pink to Help Fight Breast Cancer

Tue, 15 Sep 2009 15:00:00 0500

STOCKTON, Calif.-(Business Wire)-September 15, 2009 - Cozying up to a fire will take on new meaning this fall: supporting the fight against breast cancer. Duraflame (IntrinsiQ, the company improving the quality and understanding...

Groundbreaking Breast Cancer Radiation Technique Delivers Proven Long-Term Benefits and Saves Lives

Tue, 15 Sep 2009 13:42:00 0500

SUNNYVALE, Calif.-(Business Wire)-September 15, 2009 - One minute of radiation in the operating room (OR) could save the lives of thousands of women being treated for breast cancer in the US today. According to a growing body of research, a 60-second course of radiation therapy delivered during...

Orange County Set to Race for the Cure®

Tue, 15 Sep 2009 13:00:00 0500

COSTA MESA, Calif.-(Business Wire)-September 15, 2009 - Grab your running or walking shoes, don some pink and help make an impact by taking the new “125 Challenge” along with more than 30,000 activists and Order bookings rose 19* percent.
Net sales increased by 15* percent.

Free Resource for Cancer Patients and Families in Tough Economic Times

Tue, 15 Sep 2009 10:00:00 0500

APEX, N.C.-(Business Wire)-September 15, 2009 - The NavigateCancer Foundation (NCF), a nonprofit staffed by oncology professionals, provides patient advocacy tools and services for cancer patients and families, is filling an especially vital role as the ranks of the unemployed and uninsured...

Cytheris Announces Interim Data from INSPIRE Study Showing Interleukin-7 (CYT107) Induces Dose-Dependent and Sustained Increase of CD4 T Cells in Chronic HIV-Infected Patients

Tue, 15 Sep 2009 10:00:00 0500

PARIS-(Business Wire)-September 15, 2009 - Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced presentation of data from an interim analysis of CLI-107-06 (INSPIRE), a Phase I/IIa study of HIV-infected...

BioAlliance Pharma Makes Four Presentations at the 49th ICAAC Meeting Including Three Phase III Study Results with miconazole Lauriad® and One with Its Integrase Inhibitor

Tue, 15 Sep 2009 05:30:00 0500

PARIS-(Business Wire)-September 15, 2009 - Regulatory News:

BioAlliance Pharma has attended the 49^th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad® and anti-integrase...

Breast Preservation Foundation Urges Washington Policymakers to Consider Public Health Education Programs in Health Care Reform Discussions

Mon, 14 Sep 2009 17:46:00 0500

LOS ANGELES-(Business Wire)-September 14, 2009 - Amidst the ongoing health-policy debate, Los Angeles...

Omnyx Announces the Award of a Digital Pathology Patent to Reduce Scan Times and Increase Image Quality

Mon, 14 Sep 2009 16:00:00 0500

PITTSBURGH-(Business Wire)-September 14, 2009 - Omnyx, a joint venture of GE Healthcare and The University of Pittsburgh Medical Center, has announced the United States Patent and Trademark Office has issued patent no. 7576307 covering dual image sensors for rapid autofocusing. This technology...

Research and Markets: Assess Ten-Year Test Volume and Sales Forecasts for 40 Cancer Diagnostic Procedures Performed in French Hospitals and Commercial Laboratories inside Latest Report

Mon, 14 Sep 2009 16:00:00 0500

DUBLIN-(Business Wire)-September 14, 2009 - Research and Markets (RedPath Integrated Pathology, Inc., a...

University of Maryland Greenebaum Cancer Center the Latest Top Cancer Center to Adopt Calypso Medical’s “GPS for the Body” Tumor-Tracking Technology

Mon, 14 Sep 2009 13:00:00 0500

SEATTLE-(Business Wire)-September 14, 2009 - Calypso Medical Technologies, Inc., a...

BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference

Mon, 14 Sep 2009 12:30:00 0500

ELMWOOD PARK, N.J.-(Business Wire)-September 14, 2009 - BioReference Laboratories, Inc (NASDAQ:BRLI) announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the 2009 UBS Global Life Sciences Conference on Monday, September 21, 2009, at The...

PolyMedix to Make Three Presentations of Antibiotic Data at the 49Th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

Mon, 14 Sep 2009 12:30:00 0500

RADNOR, Pa.-(Business Wire)-September 14, 2009 - PolyMedix, Inc. (OTC BB: PYMX,

Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate

Mon, 14 Sep 2009 12:00:00 0500

NEEDHAM, Mass.-(Business Wire)-September 14, 2009 - Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that the first patient has been dosed in a Phase 1/2 study of its vaccine candidate, CDX-1401, in patients with malignant solid tumors that express NY-ESO-1. CDX-1401 is a fully human...

ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas

Mon, 14 Sep 2009 11:35:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 14, 2009 - ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA...

Celsion and the American Liver Foundation Partner to Promote Awareness of Primary Liver Cancer and the ThermoDox® Phase III Global HEAT Study to Patients and Physicians

Mon, 14 Sep 2009 11:30:00 0500

COLUMBIA, Md. & NEW YORK-(Business Wire)-September 14, 2009 - Celsion Corporation (NASDAQ:CLSN) and the American Liver Foundation (ALF) announced today that they have formed a partnership to provide education to physicians and liver patients about the treatment options for hepatocellular...

Research and Markets: A Comprehensive Analysis of the German Cancer Diagnostics Market

Mon, 14 Sep 2009 10:11:00 0500

DUBLIN-(Business Wire)-September 14, 2009 - Research and Markets (The Albert and Mary Lasker...

Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia (CAP) at ICAAC

Sat, 12 Sep 2009 18:35:00 0500

SAN FRANCISCO-(Business Wire)-September 12, 2009 - Forest Laboratories, Inc (NYSE: FRX) today presented at the 49^th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter...

Citizens for Health to Hold Press Conference—“Living With Brain Tumors”—Monday, September 14th Immediately Following Senate Hearings on “The Health Effects of Cell Phones” Organized by Sen. Arlen Specter

Sat, 12 Sep 2009 16:42:00 0500

WASHINGTON-(Business Wire)-September 12, 2009 - Citizens for Health (www.citizens.org) will host a press...

Research and Markets: Ovarian Cancer - A Concise Analysis of the Most Important Information About this Disease, its Treatment and Market Opportunities

Fri, 11 Sep 2009 18:00:00 0500

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets (

Research and Markets: The US Cancer Diagnostics Market - Includes Mortality Statistics, Scientific Views, Sales Forecasts and Much More

Fri, 11 Sep 2009 15:00:00 0500

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets (

Research and Markets: Ovarian Cancer Therapy Area Pipeline Report

Fri, 11 Sep 2009 13:37:00 0500

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets (

Research and Markets: The UK Cancer Diagnostics Market Feature Ten-Year Test Volume and Sales Forecasts for 40 Cancer Diagnostic Procedures

Fri, 11 Sep 2009 11:57:00 0500

DUBLIN-(Business Wire)-September 11, 2009 - Research and Markets(IntrinsiQ president Jeff Forringer will discuss...

Millennium Initiates Phase II Trial of Prostate Cancer Compound

Fri, 11 Sep 2009 07:00:00 0500

CAMBRIDGE, Mass.-(Business Wire)-September 11, 2009 - Takeda Pharmaceutical Company Limited...

Who:

Digital50.com Oncology News RSS Feed

Curves Joins Breast Cancer Awareness Campaign